Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Baxter
 More »

  • What the Top 15 Biopharma CEOs Are Making
    proxy filings with the SEC, Baxter International Chairman and CEO Robert L. Parkinson finished 2012 with $17,521,770 in total compensation, up 24.6% from the previous year. ...
    7-31-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    and manufacturing positions (Novartis, Baxter, Impax, and to a lesser extent ... results disclosed April 25. #5. Baxter International Number of job layoffs ...
    7-11-2013
  • Biogen Idec, Sobi Cite Promising Phase III Results for Hemophilia...
    At ISTH, Baxter presented data showing Advate's effect on "peaks" when patients had the ... design individual dosing regimens to reduce bleed frequency, Baxter said in a statement. ...
    7-5-2013
  • FDA Approves Baxter's Rixubis for Hemophilia B
    has approved Baxter International's Rixubis for use in hemophilia B patients 16 and up. ... In a Baxter statement, Val Bias, chief executive officer of the National Hemophilia ...
    7-1-2013
  • Biopharma Layoffs: Relocate or Not?
    have prompted drug and diagnostics companies to step up job reductions. Eli Lilly, Baxter International, Bristol-Myers Squibb, Novartis, and Roche are among the pharma ...
    6-19-2013
  • Caution: Falling Job Zone
    Pharma giants disclosing job cuts in 2013 through June 13 include Eli Lilly (1,000 sales reps), Baxter International (400 in Puerto Rico), Bristol-Myers Squibb (about 400 in San ...
    6-14-2013
  • Top 20 Corporate Venture Funds
    ... or diagnostics; North American and European regions Year established: 2001 #5. (tie) Baxter Ventures Resources: $200 million Current portfolio: Seven investments, most being ...
    6-14-2013
  • Seeking New Tools Against Alzheimer's
    May, when Baxter International's Gammagard failed in Phase III to reduce cognitive decline or preserve functional ability in mild-to-moderate Alzheimer's patients. Baxter did point ...
    6-7-2013
  • Vaccine Advances Drive Differentiation
    ... In November 2012, Novartis' Flucelvax® became the first mammalian cell-based flu vaccine approved by the FDA. GSK, Astellas, Sanofi, Baxter International, and AstraZeneca also are ...
    6-1-2013
  • Alzheimer's Research
    Baxter International's drug candidate Gammagard is the latest Alzheimer's therapeutic to fail in meeting its clinical endpoints. A number of other potential therapies have suffered ...
    5-7-2013
  • Another Alzheimer's Drug Fails Phase III Trial
    Baxter International acknowledged today that its Phase III drug candidate Gammagard ... According to topline results released by Baxter, patients with mild to moderate ...
    5-7-2013
  • CEO Perks
    ... Baxter International, chairman and CEO Perks and "all other" compensation: $9,012, ... these perquisites was less than $10,000," Baxter stated in its Proxy Statement, filed ...
    4-12-2013
  • Ipsen Enlists PeptiDream in Search for Therapeutic Peptides
    news for Ipsen, which recently, along with bankrupt company Inspiration Biopharmaceuticals, sold its rights to hemophilia drugs OBI-1 to Baxter International and IB1001 to Cangene. ...
    4-10-2013
  • Is This Gene Therapy's Breakout Moment?
    Also last June, Baxter International agreed to develop and commercialize potential ... Baxter agreed to pay $25 million up front, and additional payments tied to development and ...
    4-1-2013
  • Is This Gene Therapy's Breakout Moment?
    ... Also last June, Baxter International agreed to develop and commercialize potential ... Baxter agreed to pay $25 million up front, and additional payments tied to development and ...
    3-4-2013
  • More »

    Journal Articles

  • Factors Affecting Purification of CD34 + Peripheral Blood Stem...
    Jeffrey Gryn, Richard K. Shadduck, John Lister, Zella R. Zeigler, Jane M. Raymond
    Stem Cells and Development
    Factors Affecting Purification of CD34 + Peripheral Blood Stem Cells Using the Baxter Isolex 300i Stem Cells and Development
  • Comparative Evaluation of Procedures with a Baxter CS-3000 Cell...
    Atsushi Makimoto, Yoshifumi Kawano, Takanori Abe, Yasuhiro Okamoto, Junko Sato, Ryuji Nakagawa, Hiroyoshi Watanabe, Tsutomu Watanabe, Yasuhiro Kuroda, Lisa Sweet, Yoichi Takaue
    Stem Cells and Development
    Comparative Evaluation of Procedures with a Baxter CS-3000 Cell Separator for Collecting Peripheral Blood Cells from Children Stem Cells and Development
  • Corporate Profile: Baxter, Sustaining health and the environment...

    Sustainability: The Journal of Record
    Corporate Profile: Baxter, Sustaining health and the environment at a global medical products and services company Sustainability: The Journal of Record
  • In Memoriam John D. Baxter, M.D., 1940-2011
    Thomas S. Scanlan, Robert J. Fletterick
    Thyroid
    In Memoriam John D. Baxter, M.D., 1940-2011 Thyroid

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll